The abstract is read at the publisher; the summary is JClub's.
In a CCl-induced mouse model of liver fibrosis, fibrosis progression is linked to a stage-wise loss of 5hmC alongside decreased TET1 and increased TET3 protein levels.
- Why it matters: Progressive epigenetic dysregulation is associated with hepatic pathology, but how hydroxymethylation and TET balance shift during fibrosis and regeneration remains unclear.
- What they did: The study measured 5hmC by immunostaining and TET1/TET3 by immunoblotting in fibrotic and regenerating mouse livers, then tested 5-Azacytidine in vivo and in mouse primary and human LX-2 stellate cells.
- The result: 5-Azacytidine improved liver morphology, lowered serum AST and ALT, restored 5hmC and TET1 while downregulating TET3, and reduced fibrogenic markers -smooth muscle actin and Collagen-I.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.